Key Financial Data Of Reporting Company

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7553053

Concept As at
2023-05-31
2023-03-01 to
2023-05-31
As at
2023-02-28
2022-03-01 to
2023-02-28
As at
2022-05-31
2022-03-01 to
2022-05-31
Key financial data of reporting company
Business results of reporting company
Net sales
32,096,000,000 JPY
128,330,000,000 JPY
26,393,000,000 JPY
Ordinary profit (loss)
5,713,000,000 JPY
16,051,000,000 JPY
2,298,000,000 JPY
Net assets
261,629,000,000 JPY
258,408,000,000 JPY
251,713,000,000 JPY
Total assets
320,184,000,000 JPY
313,917,000,000 JPY
307,764,000,000 JPY
Basic earnings (loss) per share
52.09
148.01
20.46
Diluted earnings per share
52.05
147.88
20.45
Equity-to-asset ratio
0.809 xbrli:pure
0.816 xbrli:pure
0.811 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.